Amit Sachdev - 10 Feb 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Chief Patient Officer
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
10 Feb 2023
Net transactions value
-$2,157,492
Form type
4
Filing time
14 Feb 2023, 16:06:18 UTC
Previous filing
03 Feb 2023
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $768,496 -2,611 -3.3% $294.33 77,141 10 Feb 2023 Direct
transaction VRTX Common Stock Tax liability $1,388,997 -4,657 -6% $298.26 72,484 13 Feb 2023 Direct
holding VRTX Common Stock 882 10 Feb 2023 401(k)
holding VRTX Common Stock 8,861 10 Feb 2023 Held in Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.